Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Capital Expenditures: 2011-2013

Historic Capital Expenditures for SELLAS Life Sciences Group (SLS) over the last 3 years, with Sep 2013 value amounting to $104,000.

  • SELLAS Life Sciences Group's Capital Expenditures fell 85.93% to $104,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $2.8 million, marking a year-over-year decrease of 6.26%. This contributed to the annual value of $6,000 for FY2016, which is 98.88% down from last year.
  • SELLAS Life Sciences Group's Capital Expenditures amounted to $104,000 in Q3 2013, which was down 91.25% from $1.2 million recorded in Q2 2013.
  • In the past 5 years, SELLAS Life Sciences Group's Capital Expenditures registered a high of $1.2 million during Q2 2013, and its lowest value of $40,000 during Q1 2011.
  • In the last 3 years, SELLAS Life Sciences Group's Capital Expenditures had a median value of $739,000 in 2013 and averaged $650,600.
  • Per our database at Business Quant, SELLAS Life Sciences Group's Capital Expenditures surged by 1,747.50% in 2012 and then tumbled by 85.93% in 2013.
  • Over the past 3 years, SELLAS Life Sciences Group's Capital Expenditures (Quarterly) stood at $739,000 in 2011, then remained steady at $739,000 in 2012, then plummeted by 85.93% to $104,000 in 2013.
  • Its last three reported values are $104,000 in Q3 2013, $1.2 million for Q2 2013, and $739,000 during Q1 2013.